Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) Operating Expenses & History | Stock Alarm

Demo Sign up Log In

Teva Pharmaceutical Industries Limited American Depositary Shares · Operating Expenses

TEVA Operating Expenses

Latest reported$7.10Bperiod endingJun 30, 2026

TEVA Operating Expenses ($20.50M → $7.10B)

Annual operating expenses

High-resolution chart · PNG

TEVA operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares Operating Expenses — Annual fiscal periods (USD)
Period ending	Operating Expenses (USD)
Dec 31, 2025	6,780,000,000
Dec 31, 2024	8,366,000,000
Dec 31, 2023	7,212,000,000
Dec 31, 2022	9,170,000,000
Dec 31, 2021	5,878,000,000
Dec 31, 2020	11,298,000,000
Dec 31, 2019	7,979,000,000
Dec 31, 2018	5,427,000,000
Dec 31, 2017	6,834,000,000
Dec 31, 2016	7,207,000,000
Dec 31, 2015	6,242,000,000
Dec 31, 2014	6,566,000,000
Dec 31, 2013	6,746,000,000
Dec 31, 2012	6,473,000,000
Dec 31, 2011	5,505,000,000
Dec 31, 2010	4,766,000,000
Dec 31, 2009	4,301,000,000
Dec 31, 2008	4,823,000,000
Dec 31, 2007	2,482,000,000
Dec 31, 2006	2,163,000,000
Dec 31, 2005	1,167,700,000
Dec 31, 2004	1,064,900,000
Dec 31, 2003	634,100,000
Dec 31, 2002	571,400,000
Dec 31, 2001	470,837,000
Dec 31, 2000	411,654,000
Dec 31, 1999	384,157,000
Dec 31, 1998	334,800,000
Dec 31, 1997	314,200,000
Dec 31, 1996	274,100,000
Dec 31, 1995	188,400,000
Dec 31, 1994	175,300,000
Dec 31, 1993	145,500,000
Dec 31, 1992	120,900,000
Dec 31, 1991	80,900,000
Dec 31, 1990	97,400,000
Dec 31, 1989	56,200,000
Dec 31, 1988	59,100,000
Dec 31, 1986	35,400,000
Dec 31, 1985	20,500,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.